Prosecution Insights
Last updated: April 19, 2026
Application No. 17/999,535

USE OF MTW-ZEOLITE IN SUPPORT FOR HYDROCRACKING CATALYSTS WITH IMPROVED SELECTIVITY AND COLD FLOW PROPERTY OF MIDDLE DISTILLATE

Non-Final OA §103
Filed
Nov 21, 2022
Examiner
ROBINSON, RENEE E
Art Unit
1772
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Chevron U S A Inc.
OA Round
3 (Non-Final)
74%
Grant Probability
Favorable
3-4
OA Rounds
2y 11m
To Grant
97%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allow Rate
759 granted / 1029 resolved
+8.8% vs TC avg
Strong +24% interview lift
Without
With
+23.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
35 currently pending
Career history
1064
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
43.3%
+3.3% vs TC avg
§102
14.9%
-25.1% vs TC avg
§112
29.2%
-10.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1029 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 26 November 2025 has been entered. Response to Arguments Applicant's arguments filed 26 November 2025 have been fully considered but they are not persuasive. The declaration under 37 CFR 1.132 filed 26 November 2025 is insufficient to overcome the rejection of the claims based upon the Domokos reference as set forth in the last Office action because: In the declaration, Dr. Zhan establishes that the 1.27 wt% increase in middle distillate production between comparative catalyst B and exemplary catalyst C is significant because it can generate more than one million USD per year for a hydrocracker having a capacity of 30,000 barrels per day (par. 9). Dr. Zhan further contends that Figures 1 & 2 show improved cold flow properties when using catalyst C in comparison to catalyst B (par. 10). The office appreciates that this tends to show an improvement when comparing catalysts B and C. However, the evidence of record as a whole, including the data provided in the specification and the declaration by Dr. Zhan, is insufficient to patentably distinguish the instant claimed catalyst over the prior art of record (in particular, Domokos). As a preliminary matter, Applicant has not addressed the very minor difference in performance which exists between comparative catalyst A and exemplary catalyst C. Like catalyst B, catalyst A also differs from exemplary catalyst C in that it does not contain a ZSM-12 component. However, the middle distillate selectivity differs between these two catalysts (A & C) by only 0.31 wt%. As stated in the final office action, this difference is small enough that it would be considered within the margin of error for different experiments using the same catalyst. While Dr. Zhan provides an analysis between catalysts B and C, those containing the largest difference, the declaration fails to explain the data between catalysts A and C and whether the very minor difference in performance amounts to anything of significant value. Accordingly, there lacks sufficient evidence establishing that the presence of ZSM-12 alone accounts for significant improvements as alleged. The office reiterates that Domokos discloses the zeolite component being one or more of zeolite Y, ZSM-5, ZSM-12, and zeolite beta, where the zeolite Y is USY (see [0026]-[0027], emphasis added). This is a very finite list of suitable zeolites, including explicit suggestions of combinations of the list. Applicant’s claimed three zeolites are in this small list of Domokos. In fact, Domokos’ list contains only one additional zeolite (ZSM-5) not required by the claims (however, neither is it excluded). Furthermore, Domokos discloses a combination of alumina and ASA as suitable refractory oxide material of the HDC catalyst (see [0032]). Accordingly, the office maintains the position that Domokos provides clear suggestion to include all of the five components as a HDC catalyst base. Additionally, with respect to Applicant’s arguments, the office notes that Applicant refers to catalysts C and D as “catalysts consistent with the present claims.” However, as pointed out in the final office action, the office respectfully submits that this is not the case as it relates to catalyst D. Catalyst D does not contain a beta zeolite component and is therefore not consistent with the present claims. As such, the data used for comparison by the office include those presented between comparative catalysts A and B with that of exemplary catalyst C (in line with the scope of the instant claims). Given that the evidence of record, when considered as a whole as it relates to the claimed invention, is insufficient to show unexpected results, the rejection based upon Domokos is maintained. Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claims 19-27 are rejected under 35 U.S.C. 103 as being unpatentable over Domokos et al (US 2006/0207917). Regarding claim 19, Domokos discloses a hydrocracking catalyst comprising a base including a zeolite component and a refractory oxide component (see [0001]; [0015]). The zeolite component may be a combination of two or more different zeolite types, wherein suitable zeolites include USY, beta zeolite, and ZSM-12 (see [0024]; [0026]-[0027]). The refractory oxide component may be alumina and amorphous silica-alumina (ASA), including in combination (see [0032]). Accordingly, Domokos discloses a HDC catalyst base which may include all of the claimed components. While the reference does not explicitly disclose an embodiment with all of the claimed species together in one catalyst, the reference makes very clear that such species may be used in combination. Arriving at a composition as claimed is therefore obvious in light of the Domokos disclosure, would be achieved by routine experimentation, and associated with a reasonable expectation of success. Regarding claims 20-25, Domokos discloses wherein the zeolite content is in the range of 1 to 85 wt% and the refractory oxide content is in the range of from 0 to 70 wt% (see [0046]-[0047]). Determining the amounts of the individual components within the respective groups amounts to nothing more than routine experimentation for a person of ordinary skill in the art. Absent a showing of criticality of unexpected results, the claimed concentrations of the catalyst components are not considered to patentably distinguish over the cited prior art. Regarding claim 26, Domokos discloses the catalyst comprising nickel and tungsten (see [0020]; [0139]). Regarding claim 27, Domokos discloses a total amount of Group VIII (nickel) and Group VIB (tungsten) metals in the range of 25 to 50 wt%, with a molar ratio of Group VIII metal to Group VIB metal in the range of 0.5:1 to 3:1 (see [0043]-[0044]), thus corresponding the concentrations overlapping with those claimed. Claims 28-34 are rejected under 35 U.S.C. 103 as being unpatentable over Domokos in view of Kijlstra et al (US 2015/0126791). Regarding claims 28-30, Domokos does not disclose the hydrocracking catalyst comprising a modifying agent. Kijlstra discloses a hydrocracking catalyst comprising zeolite, refractory oxide, and catalytically active metals (see Abstract). In particular, Kijlstra discloses that inclusion of citric acid can improve naphtha-selective catalytic properties, where citric acid is thought to facilitate metal deposition thereby balancing the hydrogenation activity and the cracking activity (see [0008]). It would have been obvious to a person of ordinary skill in the art at the time of filing the instant claimed invention to modify the catalyst of Kijlstra to include a citric acid component, as suggested by Kijlstra, in order to balance hydrogenation activity and cracking activity when used in hydrocracking processes. Regarding claims 31-34, Domokos discloses and/or suggests the catalyst components described above and Kijlstra provides the motivation for including a citric acid modifying agent, all of which applies to the catalyst encompassed by the aforementioned claims. The claims are directed to a product-by-process. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process. The office further notes that preparation techniques in line with those set forth in the claims are known in the art (see Domokos: [0062]; [0138]-[0139]). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to RENEE ROBINSON whose telephone number is (571)270-7371. The examiner can normally be reached Monday - Thursday 8:00a-5:00p and Friday 8:00a-2:00p. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, In Suk Bullock can be reached at (571)272-5954. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Renee Robinson/Primary Examiner, Art Unit 1772
Read full office action

Prosecution Timeline

Nov 21, 2022
Application Filed
Sep 05, 2024
Non-Final Rejection — §103
Dec 06, 2024
Response Filed
Jan 24, 2025
Final Rejection — §103
Jun 30, 2025
Notice of Allowance
Aug 19, 2025
Examiner Interview Summary
Aug 19, 2025
Applicant Interview (Telephonic)
Nov 26, 2025
Request for Continued Examination
Nov 26, 2025
Response after Non-Final Action
Nov 28, 2025
Response after Non-Final Action
Dec 16, 2025
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599883
SCREENING ASSEMBLY AND PROCESS FOR SCREENING POLYMER FROM AN EFFLUENT STREAM AT REDUCED LEVELS OF POLYMER ENTRAINMENT
2y 5m to grant Granted Apr 14, 2026
Patent 12595426
PROCESS FOR REMOVING CONTAMINANTS FROM CRUDE OIL
2y 5m to grant Granted Apr 07, 2026
Patent 12577477
PROCESS AND SYSTEM FOR UPGRADING HYDROCRACKER UNCONVERTED HEAVY OIL
2y 5m to grant Granted Mar 17, 2026
Patent 12577198
ACETONITRILE SEPARATION PROCESS
2y 5m to grant Granted Mar 17, 2026
Patent 12577475
PROCESS FOR CONVERSION OF VERY LIGHT, SWEET CRUDE OIL TO CHEMICALS
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
74%
Grant Probability
97%
With Interview (+23.5%)
2y 11m
Median Time to Grant
High
PTA Risk
Based on 1029 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month